NCT07482124 Multicenter Registry of Patients With Subarachnoid Hemorrhage
| NCT ID | NCT07482124 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UMC Utrecht |
| Condition | Subarachnoid Hemorrhage, Spontaneous |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-02-12 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-02-12 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry is to collect detailed information on the characteristics, treatment, and outcomes of patients with a subarachnoid hemorrhage. This information will enable research aimed at improving the safety and effectiveness of current and future treatments. By studying these data, the investigators aim to identify which treatment strategies offer the best results and which factors are most important in the care of patients with a subarachnoid hemorrhage. The knowledge gained from this research will help improve patient care in the future.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Spontaneous subarachnoid hemorrhage with blood in the basal cisterns and/or major fissures on non-contrast head computed tomography (CT), or xanthochromia of cerebrospinal fluid confirmed by spectrophotometric analysis. * Eligible etiologies/patterns: * Aneurysmal SAH * SAH from other intracranial vascular malformation (e.g. AVM, dural AVF) * Perimesencephalic SAH * Non-perimesencephalic angiogram negative SAH * SAH from intracranial artery dissection Exclusion Criteria: * Traumatic, neoplastic, infection related (except mycotic aneurysms), or iatrogenic SAH * Isolated convexity SAH
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07482124 clinical trial?
This trial is open to participants of all sexes, studying Subarachnoid Hemorrhage, Spontaneous. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07482124 currently recruiting?
Yes, NCT07482124 is actively recruiting participants. Contact the research team at measure@umcutrecht.nl for enrollment information.
Where is the NCT07482124 trial being conducted?
This trial is being conducted at Nijmegen, Netherlands, Maastricht, Netherlands, Tilburg, Netherlands, Amsterdam, Netherlands and 5 additional locations.
Who is sponsoring the NCT07482124 clinical trial?
NCT07482124 is sponsored by UMC Utrecht. The trial plans to enroll 1,000 participants.